A big reason for Resmed’s recently announced rebrand is to reflect its increased direct-to-consumer engagement on obstructive sleep apnea and CPAP therapy. Chief Marketing Officer Katrin ...
SAN DIEGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), a global health technology leader focused on sleep, breathing, and care delivered in the home, today unveiled the ...
SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...
“For people with OSA, using CPAP versus not using CPAP can literally be a matter of life or death,” said Carlos Nunez, M.D., Resmed’s Chief Medical Officer. “Decades of research have shown CPAP can ...
CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea, according to a landmark meta-analysis supported by Resmed and published in The Lancet Respiratory Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results